Welcome to the Media Centre
This section provides details of new items added to the site as well as a full archive of our press releases and statements.
The opening hours for the Press Office are Monday to Friday between 9:00 and 17:00.
The Press Office
5th Floor
151 Buckingham Palace Road
Victoria
LONDON
SW1W 9SZ
Main telephone: 020 3080 7651
Out of hours: 07770 446 189
press.office@mhra.gsi.gov.uk
For urgent calls outside these press office hours please contact the duty press officer on : 07770 446 189.
We now have a Twitter channel for press releases and news statements, giving you another way to find out the latest news from the MHRA in real time.
Follow @MHRApress
Press enquiries should be made through the Press Office.
Latest news and press releases
14 Jun 2013 | MHRA press statement on Hydroxyethyl Starch (HES) containing solutions
The MHRA have released a statement on Hydroxyethyl Starch (HES) containing solutions.
14 Jun 2013 | Press statement: MHRA responds to European Medicines Agency recommendation on codeine
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency has recommended that codeine-containing medicines should only be used in children over 12 years old to treat acute (short lived) moderate pain, and only if it cannot be relieved by other painkillers such as paracetamol or ibuprofen.
14 Jun 2013 | Press statement: MHRA responds to European Medicines Agency recommendation on diclofenac
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency has recommended that patients with serious underlying heart conditions, such as heart failure, heart disease, circulatory problems or a previous heart attack or stroke should not use diclofenac.
14 Jun 2013 | MHRA press statement on Ranbaxy
Statement on Ranbaxy following from the US justice department announcing that Ranbaxy USA Inc. a subsidiary of Ranbaxy Laboratories limited had pleaded guilty to felony charges relating to the manufacture and distribution of adulterated drugs made at two facilities in India.
12 Jun 2013 | Press release: UK moves towards safe and effective electronic cigarettes and other nicotine-containing products
All nicotine-containing products (NCPs), such as electronic cigarettes, are to be regulated as medicines in a move to make these products safer and more effective to reduce the harms of smoking.
Photo and image library
What's new
Press releases
This section of the site includes press releases and statements issued by the MHRA.
Press Office contacts
